Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...

Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...

An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...

New data from the MK-8591A-051 and MK-8591A-052 trials, both investigating the efficacy and safety of 100-mg doravirine and 0.25-mg islatravir as a once-daily 2-drug regimen for virologically ...

Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...

In the fight against HIV, one of the most vulnerable populations is often overlooked - newborn babiesIt is estimated that 120,000 new HIV infections occur in children aged 14 years and younger every ...

Adults living with HIV in Malawi are more than twice as likely to also have dementia compared to those without HIV, according ...

“HIV treatment is crumbling ... s transpired over the last three or four days just takes it to a whole new level of cruelty and inhumanity and, frankly, a whole new level of stupidity ...

Adults living with HIV in Malawi are more than twice as likely to also have dementia compared to those without HIV, according ...

Debates over tuberculosis reporting began in the late 19th century, when the bacterial infection was reframed not as a disease of the elite but of the urban poor. New York City was the first in the ...